Research Topic

Bacteriophages and their Lytic Enzymes as Alternative Antibacterial Therapies in the Age of Antibiotic Resistance

About this Research Topic

Over the last few decades, bacterial resistance to antibiotics has turned into a major global health problem that the World Health Organization currently recognizes as an urgent priority. A growing number of infections are becoming almost impossible to treat, leading to increased morbidity, mortality, and ...

Over the last few decades, bacterial resistance to antibiotics has turned into a major global health problem that the World Health Organization currently recognizes as an urgent priority. A growing number of infections are becoming almost impossible to treat, leading to increased morbidity, mortality, and economical burden. This global challenge is provoking high interest in treatment options as alternative to traditional antibiotics. The use of bacteriophages and their derived lytic enzymes have recently emerged as a promising strategy to combat antibiotic resistant bacterial infections.

With the recent escalation of antibiotic resistance, phage therapy faced a rebirth. The antibacterial character of phages and their lytic proteins – peptidoglycan-cleaving enzymes with the ability to disrupt bacterial cell walls (enzybiotics) - has been intensively explored as hopeful alternatives to conventional antibiotics. Advances in this field are crucial for the development of novel antimicrobial therapies that are efficient against bacteria recalcitrant to antibiotic treatments. The number of case reports describing the use of phages or their lysins in difficult to treat infections has increased significantly in recent years. The aim of this Research Topic is to provide readers with an updated overview of the field, highlighting the most recent advances in the use of phages or lysins for the prevention and/or control of infections, both in pre-clinical and clinical settings.

This Research Topic will accept Original Research, Perspective, Minireviews and Opinion articles on the implementation of phages or phage lysins in the following contexts:
• Biofilm prevention and control
• Synergistic combinations with other antimicrobials
• Drug delivery systems for the release at the site of infection
• Safety and host Immune response
• Engineered variants of phage and lytic enzymes
• Therapies modulating host microbiota


Keywords: Phage therapy, lysins, antibiotic resistance, enzybiotics


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Recent Articles

Loading..

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Topic Editors

Loading..

Submission Deadlines

03 April 2021 Manuscript
25 November 2021 Manuscript Extension

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..

Topic Editors

Loading..

Submission Deadlines

03 April 2021 Manuscript
25 November 2021 Manuscript Extension

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..
Loading..

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..